Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Current Clinical Pharmacology
|
January 20, 2009
State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases
Mark A Babizhayev, Anne Kasus-Jacobi
Journal of Drug Targeting
|
November 28, 2008
N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications
Mark A Babizhayev, Andrea Guiotto, Anne Kasus-Jacobi
Advances in Wound Care
|
June 16, 2017
Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections
Gina L Griffith, Anne Kasus-Jacobi, H Anne Pereira
Journal of Neuroinflammation
|
August 29, 2018
The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease
Amanda J Stock, Anne Kasus-Jacobi, H Anne Pereira
American Journal of Therapeutics
|
June 3, 2009
N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients
Mark A Babizhayev, Philip Micans, Andrea Guiotto, et al.
Fundamental & Clinical Pharmacology
|
July 29, 2011
Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care
Mark A Babizhayev, Inna P Khoroshilova-Maslova, Anne Kasus-Jacobi
Journal of Ocular Diseases and Therapeutics
|
December 14, 2018
Effect of Cationic Antimicrobial Protein CAP37 on Cytokine Profile during Corneal Wound Healing
Anne Kasus-Jacobi, Gina L Griffith, Megan Lerner, et al.
Investigative Ophthalmology & Visual Science
|
July 17, 2014
Corneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCδ)
Gina L Griffith, Anne Kasus-Jacobi, Megan R Lerner, et al.
Current Alzheimer Research
|
August 25, 2021
Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity
Anne Kasus-Jacobi, Jennifer L Washburn, Craig A Land, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 10, 2014
Novel neuroendocrine and metabolic mechanism provides the patented platform for important rejuvenation therapies: targeted therapy of telomere attrition and lifestyle changes of telomerase activity with the timing of neuron-specific imidazole-containing dipeptide-dominant pharmaconutrition provision
Mark A Babizhayev, Anne Kasus-Jacobi, Khava S Vishnyakova, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Current Clinical Pharmacology
|
January 20, 2009
State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases
Mark A Babizhayev, Anne Kasus-Jacobi
Journal of Drug Targeting
|
November 28, 2008
N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications
Mark A Babizhayev, Andrea Guiotto, Anne Kasus-Jacobi
Advances in Wound Care
|
June 16, 2017
Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections
Gina L Griffith, Anne Kasus-Jacobi, H Anne Pereira
Journal of Neuroinflammation
|
August 29, 2018
The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease
Amanda J Stock, Anne Kasus-Jacobi, H Anne Pereira
American Journal of Therapeutics
|
June 3, 2009
N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients
Mark A Babizhayev, Philip Micans, Andrea Guiotto, et al.
Fundamental & Clinical Pharmacology
|
July 29, 2011
Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care
Mark A Babizhayev, Inna P Khoroshilova-Maslova, Anne Kasus-Jacobi
Journal of Ocular Diseases and Therapeutics
|
December 14, 2018
Effect of Cationic Antimicrobial Protein CAP37 on Cytokine Profile during Corneal Wound Healing
Anne Kasus-Jacobi, Gina L Griffith, Megan Lerner, et al.
Investigative Ophthalmology & Visual Science
|
July 17, 2014
Corneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCδ)
Gina L Griffith, Anne Kasus-Jacobi, Megan R Lerner, et al.
Current Alzheimer Research
|
August 25, 2021
Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity
Anne Kasus-Jacobi, Jennifer L Washburn, Craig A Land, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 10, 2014
Novel neuroendocrine and metabolic mechanism provides the patented platform for important rejuvenation therapies: targeted therapy of telomere attrition and lifestyle changes of telomerase activity with the timing of neuron-specific imidazole-containing dipeptide-dominant pharmaconutrition provision
Mark A Babizhayev, Anne Kasus-Jacobi, Khava S Vishnyakova, et al.
Page
of 3